NC
FCSC

Nexthera Capital’s Fibrocell Science Inc. FCSC Stock Holding History

Nexthera Capital’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,000
Closed -$137K – 50
2015
Q4 		$137K Buy
+2,000
New +$144K 0.19% 43

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nexthera Capital's FCSC Position: Q1 2016 in Review

Nexthera Capital sold out of Fibrocell Science Inc. (FCSC) in Q1 2016, closing a stake of 2,000 shares — an estimated $137K sold.

Nexthera Capital first reported a position in FCSC in Q4 2015 and held it in 1 quarter. The position peaked at $137K in Q4 2015. 52 funds tracked by Wall St. Rank hold FCSC as of Q1 2016.

  • Nexthera Capital reported no remaining Fibrocell Science Inc. position as of Q1 2016 after selling out during the quarter.
  • Nexthera Capital sold 2,000 Fibrocell Science Inc. shares in Q1 2016, an estimated $137K.
  • Nexthera Capital first reported a position in Fibrocell Science Inc. in Q4 2015 and held it in 1 quarter.
  • Nexthera Capital's Fibrocell Science Inc. position peaked at $137K in Q4 2015.
  • 52 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q1 2016.

Based on Nexthera Capital's 13F filing for Q1 2016, filed 13 May 2016.